Maturity‐Onset Diabetes of the Young (MODY) With HNF1B p.Glu105Lys Mutation Achieving Significant Insulin Reduction on Tirzepatide: A Case Report

ABSTRACT This report describes the first case of maturity‐onset diabetes in young (MODY) with HNF1B mutation started administration of the dual glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptor agonist, tirzepatide. A 26‐year‐old female with a 15‐year history of diabe...

Full description

Bibliographic Details

Published in:	Clinical Case Reports
Main Authors:	Mihiro Sue, Mayu Watanabe, Ayumi Inoue, Akihiro Katayama, Sanae Teshigawara, Yuichi Matsushita, Masaya Takeda, Izumi Iseda, Jun Eguchi, Kazuyuki Hida
Format:	Article
Language:	English
Published:	Wiley 2025-02-01
Subjects:	glucagon‐like peptide‐1 (GLP‐1) glucose‐dependent insulinotropic polypeptide (GIP) maturity‐onset diabetes in young (MODY) tirzepatide
Online Access:	https://doi.org/10.1002/ccr3.70173